Compare Enveric Biosciences Inc (ENVB) vs Kohl's Corporation (KSS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Kohl's Corporation — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Kohl's Corporation trades at $18.64 (market cap $2.10B). The key difference: Kohl's Corporation is far larger — about 338.7× Enveric Biosciences Inc's market cap, and Kohl's Corporation pays a 2.7% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | KSS | |
|---|---|---|
Market Cap | $6.20M | $2.10B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $24.71 |
52-Week Low | $1.27 | $11.72 |
Enterprise Value | $1.30M | $8.20B |
Dividend Yield | — | 2.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →
